Securities Fraud Lawsuit Filed Against Cabaletta Bio, Inc. (CABA)
A securities fraud lawsuit has been filed against Cabaletta Bio, Inc. (NASDAQ: CABA) for potential securities violations on behalf of shareholders who purchased shares anytime (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s initial public offering conducted on or about October 24, 2019; and/or (ii) between October 24, 2019 […]